rs2289367

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PP3_ModerateBP6_Very_StrongBA1

The NM_031443.4(CCM2):​c.915G>A​(p.Thr305Thr) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,602,280 control chromosomes in the GnomAD database, including 39,162 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3852 hom., cov: 32)
Exomes 𝑓: 0.22 ( 35310 hom. )

Consequence

CCM2
NM_031443.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.9997
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.17

Publications

38 publications found
Variant links:
Genes affected
CCM2 (HGNC:21708): (CCM2 scaffold protein) This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
CCM2 Gene-Disease associations (from GenCC):
  • cerebral cavernous malformation 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • famililal cerebral cavernous malformations
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 7-45073571-G-A is Benign according to our data. Variant chr7-45073571-G-A is described in ClinVar as Benign. ClinVar VariationId is 261975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCM2NM_031443.4 linkc.915G>A p.Thr305Thr splice_region_variant, synonymous_variant Exon 8 of 10 ENST00000258781.11 NP_113631.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCM2ENST00000258781.11 linkc.915G>A p.Thr305Thr splice_region_variant, synonymous_variant Exon 8 of 10 1 NM_031443.4 ENSP00000258781.7

Frequencies

GnomAD3 genomes
AF:
0.225
AC:
34144
AN:
152004
Hom.:
3847
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.254
Gnomad AMI
AF:
0.168
Gnomad AMR
AF:
0.256
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.192
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.206
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.231
AC:
56546
AN:
245312
AF XY:
0.223
show subpopulations
Gnomad AFR exome
AF:
0.249
Gnomad AMR exome
AF:
0.358
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.197
Gnomad FIN exome
AF:
0.208
Gnomad NFE exome
AF:
0.207
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.217
AC:
315144
AN:
1450158
Hom.:
35310
Cov.:
30
AF XY:
0.216
AC XY:
155638
AN XY:
721236
show subpopulations
African (AFR)
AF:
0.255
AC:
8512
AN:
33344
American (AMR)
AF:
0.344
AC:
15299
AN:
44424
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
4684
AN:
26056
East Asian (EAS)
AF:
0.178
AC:
7024
AN:
39564
South Asian (SAS)
AF:
0.216
AC:
18582
AN:
86046
European-Finnish (FIN)
AF:
0.205
AC:
10319
AN:
50308
Middle Eastern (MID)
AF:
0.182
AC:
1034
AN:
5674
European-Non Finnish (NFE)
AF:
0.215
AC:
237223
AN:
1104704
Other (OTH)
AF:
0.208
AC:
12467
AN:
60038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
11651
23302
34953
46604
58255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8416
16832
25248
33664
42080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.225
AC:
34179
AN:
152122
Hom.:
3852
Cov.:
32
AF XY:
0.224
AC XY:
16675
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.255
AC:
10566
AN:
41484
American (AMR)
AF:
0.256
AC:
3914
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
630
AN:
3472
East Asian (EAS)
AF:
0.192
AC:
991
AN:
5162
South Asian (SAS)
AF:
0.212
AC:
1025
AN:
4828
European-Finnish (FIN)
AF:
0.206
AC:
2179
AN:
10600
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14282
AN:
67978
Other (OTH)
AF:
0.189
AC:
399
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1353
2707
4060
5414
6767
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.213
Hom.:
13943
Bravo
AF:
0.233
Asia WGS
AF:
0.197
AC:
688
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cerebral cavernous malformation 2 Benign:4
Oct 10, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 23, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 24, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27708576) -

CCM2-related disorder Benign:1
Jul 02, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
19
DANN
Benign
0.77
PhyloP100
1.2
Mutation Taster
=20/80
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289367; hg19: chr7-45113170; COSMIC: COSV51849946; COSMIC: COSV51849946; API